While most of what the FDA laid out in a recent draft guidance on the assessment of overall survival in oncology clinical ...
Design Therapeutics, Inc. (($DSGN)) announced an update on their ongoing clinical study. Study Overview: Design Therapeutics, Inc. is conducting a ...
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Study Overview: Pfizer Inc. is conducting a Phase 1 study titled A PHASE ...
In a new crossover study, investigators found once-daily prednisolone was as effective as multi-dose hydrocortisone, ...
The intervention being tested is Osivelotor, a drug designed to treat sickle cell disease. The study also involves the use of Famotidine, a medication that reduces stomach acid, to assess its impact ...
Susan Galbraith, Ph.D., AZ’s oncology R&D chief, attributed Datroway’s strong efficacy to its ADC construct, specifically its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback